Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors
    Meeting Abstract

    Lito, P.; Saborowski, A.; Yue, J.; Solomon, M.; Joseph, E.; Fellman, C.; Ohara, K.; Morikami, K.; Miura, T.; Lucas, C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Context specific effects of the BRAFV600E mutation on hematopoiesis identifies novel models of BRAF mutant hematopoietic disorders
    Meeting Abstract

    Kim, E.; Chung, S. S.; Park, J. H.; Chung, Y. R.; Lito, P.; Feldstein, J.; Hu, W. H.; Beguilin, W.; Monette, S.; Duy, C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Identification of inhibitors of TWIST1 as a treatment for lung cancer
    Meeting Abstract

    Chatley, S. N.; Cades, J.; Neumann, N.; Mazzacurati, L.; Yochum, Z.; Nugent, K.; Cho, Y. J.; Ewald, A.; Rudin, C.; Tran, P.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib
    Journal Article

    Hellmann, M. D.; Reva, B.; Yu, H.; Rusch, V. W.; Rizvi, N. A.; Kris, M. G.; Arcila, M. E.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and brain metastases (BM) in the ASCEND-1 trial
    Meeting Abstract

    Shaw, A.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Mebendazole is efficacious in diverse medulloblastoma tumor models and inhibits tumor angiogenesis
    Meeting Abstract

    Bai, R. Y.; Staedtke, V.; Rudin, C.; Bunz, F.; Riggins, G.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Interim phase 2 results of study CO-1686-008: A phase 1/2 study of the irreversible, mutant selective, EGFR inhibitor rociletinib (CO-1686) in patients with advanced non small cell lung cancer
    Meeting Abstract

    Soria, J.; Sequist, L. V.; Goldman, J. W.; Wakelee, H. A.; Gadgeel, S. M.; Varga, A.; Yu, H. A.; Solomon, B. J.; Ou, S. H.; Papadimitrakopoulou, V.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Development of a Seneca Valley virus (SVV) 3C protease activated peptide prodrug
    Meeting Abstract

    Miles, L. A.; Poirier, J. T.; Rudin, C. M.
    Human Gene Therapy (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes for 61 patients with metastatic pulmonary carcinoids
    Meeting Abstract

    Litvak, A.; Iyriboz, T.; Zakowski, M.; Woo, K.; Krug, L.; Rudin, C.; Pietanza, M.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Krug, L. M.; Pietanza, M. C.; Varghese, A. M.; Won, H.; Wang, L.; Rekhtman, N.; Travis, W. D.; Litvak, A.; Paik, P. K.; Riely, G. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save